We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: If Doctors Demand Evidence and Med-Tech & Pharma Provide it, Health Care Might Cost Less
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > If Doctors Demand Evidence and Med-Tech & Pharma Provide it, Health Care Might Cost Less
BusinessMedical Devices

If Doctors Demand Evidence and Med-Tech & Pharma Provide it, Health Care Might Cost Less

Conor McKechnie
Conor McKechnie
Share
4 Min Read
The_pc_2007
SHARE

Many say medical practice is out of balance and that this lack of balance, even with much needed reform, is going to bankrupt healthcare systems in the developed world. There is too much testing, over-medicalization, over-prescribing and this is driven by the for-profit medical-industrial complex. I am not a doctor, so I cannot judge on this imbalance, only comment on my perception of the discussion about it.

Many say medical practice is out of balance and that this lack of balance, even with much needed reform, is going to bankrupt healthcare systems in the developed world. There is too much testing, over-medicalization, over-prescribing and this is driven by the for-profit medical-industrial complex. I am not a doctor, so I cannot judge on this imbalance, only comment on my perception of the discussion about it.

The_pc_2007

I’m employed by a company often considered part of the medical-industrial complex. My colleagues and I talk, all the time, argue, discuss, and research, and most importantly, make decisions intended to reduce the cost of healthcare. So what’s going on? Why the disconnect? We don’t want to be part of the problem; we’re in this to be part of the solution.

Is it culture?
Could it be that there are causes on both sides of the equation? Do the cultures of physicians and that of the industries (like the one I work in, that help physicians do their jobs), unwittingly collude to tip healthcare into this imbalance?

More Read

How AI Influences the Plastic Surgery
Health Care Spending: Why Immigrants Aren’t the Problem
There’s More to HealthCare Than Doctors and Hospitals
Covering the Needs of Patients in Nizhny Novgorod
It’s a Patient-Payer World

Technological and scientific advances, new drugs, new diagnostics, new therapies are usually more costly in the first instance than those they supercede. This, goes the narrative, leads to the inexorable rise in costs.

Because doctors, being culturally risk averse, hold no quarter in “getting the best available” for their patients, and patients, understandably, exacerbate this by demanding “the best, the latest”, even if “the best, the latest, available” is not really proven to be the “best known option” for a patient.

The medical-industrial complex, being culturally innovative, strives to produce better and better technologies, drugs and therapies to satisfy this insatiable demand of the patient-physician nexus, no matter how incremental the proven benefit.

#showmethedata
Therein, for me, lies the rub: the proven benefit. If doctors were more demanding of solid evidence for the efficacy and value delivered by medical & pharmaceutical innovations AND the medical technology and pharmaceutical industries were committed to open, transparent and rigorous demonstration of that efficacy and value, this could help reduce healthcare expenditure on “expensive and ineffective new medicines and technologies”.

The good news is there is a rising clamour on both sides beginning to agree that is beginning to spill over into public consciousness. This can only be a good thing: Campaigns such as http://choosingwisely.org/ and the rising popularity of http://www.cochrane.org activity in the reporting lay press, the position taken by research funders such as the Wellcome Trust on open data reporting, and the increasing popularity globally of health technology assessments (HTA) and comparative effectiveness research (CER), the work of England’s NICE, and not least activism by the likes of Ben Goldacre, are all pushing patients, policymakers, physicians and the industries that support healthcare delivery into candid assessments of the clinical (and often economic) value of innovation in health.

It’s not the solution, but it is part of the solution.

—

This post inspired by a year’s thinking on this NEJM article by Dr Sean Palfey and sparked by this Mother Jones post.  

 

Permalink | Leave a comment  »

TAGGED:healthcare costspharma
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Flat editorial illustration: Healthcare volunteer communication as a two-way, coordinator-supported process for confirming schedu
How to Manage Volunteer Communication in Healthcare: 5 Tactical Steps and Software Options
Global Healthcare
November 18, 2026
The Nervous System Reset Guide: Simple Ways To Manage Stress -- AI-generated illustration
The Nervous System Reset Guide: Simple Ways To Manage Stress
Infographics Mental Health
November 14, 2026
Flat editorial illustration: A single digital quality-management platform connects document control, electronic approval, audit r
6 Best QMS Software Platforms for ISO 13485 and FDA Part 820 (QMSR)
Global Healthcare Policy & Law
November 12, 2026
Flat editorial illustration: Healthcare editorial illustration about accurate patient intake connecting registration, clinical re
The Role of Patient Data Accuracy in Healthcare Operations
Global Healthcare Policy & Law
November 11, 2026

You Might also Like

Preclinical Research: An Important Aspect of Drug Development

February 5, 2014
money and steth pic
BusinessFinancePublic Health

What Size Reward Drives a Consumer to Take a Desired Health Behavior?

September 9, 2014

Maintain Interest, Create a Buzz: Simply Update Your Website!

September 8, 2014
Health careMedical DevicesSpecialtiesTechnology

The Merger of Technology and Nutrition

May 26, 2017
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?